Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

VaxGen Biopharmaceutical Manufacturing Plant

Order Year

February 2002

Project Type

New Plant

Location

South San Francisco, California, US

Estimated Investment

$11m

Completion

June 2003 on-stream

Sponsor

VaxGen, Nexol Corp, KT&G, J Stephen and Co Ventures, Celltrion

Lead Engineer / Designer

Fluor Enterprises

Validation

Fluor Enterprises, VaxGen QA

Financing

Nexol Corp, KT&G, J Stephen and Co Ventures

Type

Vaccines, protein therapeutics and monoclonal antibodies
Expand

Free download worth over $5000
Download our 2019 Technology, Media and Telecoms Predictions Report

Worth up to $5,850

In this report, we look at the 30 big tech themes for 2019, identifying winners and losers for each theme. This report will impact all industries helping:

  • CEOs/Senior Staff: in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TM
Close
Close
Close

Go Top